![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: CYBB (CAeditome ID:1536) |
Gene summary for CYBB |
![]() |
Gene information | Gene symbol | CYBB | Gene ID | 1536 |
Gene name | cytochrome b-245 beta chain | |
Synonyms | AMCBX2|CGD|CGDX|GP91-1|GP91-PHOX|GP91PHOX|IMD34|NOX2|p91-PHOX | |
Cytomap | Xp21.1-p11.4 | |
Type of gene | protein-coding | |
Description | cytochrome b-245 heavy chainCGD91-phoxNADPH oxidase 2cytochrome b(558) subunit betacytochrome b-245 beta polypeptidecytochrome b558 subunit betaheme-binding membrane glycoprotein gp91phoxneutrophil cytochrome b 91 kDa polypeptidep22 phagocyte B-cy | |
Modification date | 20210531 | |
UniProtAcc | P04839 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
CYBB | GO:0009055 | Cytochrome b-245 heavy chain | 12042318 |
CYBB | GO:0016175 | Cytochrome b-245 heavy chain | 12042318 |
CYBB | GO:0006801 | Cytochrome b-245 heavy chain | 12042318 |
CYBB | GO:0042554 | Cytochrome b-245 heavy chain | 12042318 |
CYBB | GO:0005887 | Cytochrome b-245 heavy chain | 15233623 |
CYBB | GO:0043020 | Cytochrome b-245 heavy chain | 3305576 |
Top |
RNA A-to-I events for CYBB |
![]() |
![]() |
![]() |
![]() |
CAediting_1503843(37793737, +), |
Top |
RNA editing positional annotations for CYBB using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_1503843 | chrX_37793737_+ | nonsynonymous SNV | ENST00000378588.4 | c.A410G | p.Y137C | D | P | N |
![]() |
CAeditome ID | Position | Variant type |
CAediting_1503843 | chrX_37793737_+ | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for CYBB |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for CYBB |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for CYBB |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for CYBB |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_688080 | chr9_63819626_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-4477b | 37811316 | 37811323 | 8mer-1a | 37811303 | 37811323 | 146 | -11.06 |
CAediting_688081 | chr9_63819627_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-4477b | 37811230 | 37811236 | 7mer-m8 | 37811216 | 37811237 | 153 | -12.81 |
CAediting_1229413 | chr17_67471544_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37812787 | 37812793 | 7mer-m8 | 37812769 | 37812794 | 151 | -12.96 |
CAediting_1229414 | chr17_67471546_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811947 | 37811953 | 7mer-m8 | 37811930 | 37811954 | 145 | -12.56 |
CAediting_228905 | chr2_188297554_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-561-3p | 37812334 | 37812339 | 6mer | 37812319 | 37812340 | 142 | -10.88 |
CAediting_442554 | chr5_154685830_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-1303 | 37813030 | 37813036 | 7mer-m8 | 37813016 | 37813037 | 154 | -18.95 |
CAediting_604450 | chr7_133034877_- | ENSG00000165168.7 | ENST00000378588 | hsa-miR-3654 | 37812811 | 37812817 | 7mer-m8 | 37812803 | 37812818 | 144 | -21.23 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_393 | chr1_1167164_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-200b-3p | 37813238 | 37813243 | 6mer | 37813223 | 37813244 | 143 | -8.02 |
CAediting_1306324 | chr19_13836464_- | ENSG00000165168.7 | ENST00000378588 | hsa-miR-27a-3p | 37811246 | 37811252 | 7mer-m8 | 37811232 | 37811253 | 148 | -10.57 |
CAediting_1306323 | chr19_13836462_- | ENSG00000165168.7 | ENST00000378588 | hsa-miR-27a-3p | 37811246 | 37811252 | 7mer-m8 | 37811232 | 37811253 | 148 | -10.57 |
CAediting_1229413 | chr17_67471544_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811033 | 37811039 | 7mer-m8 | 37811019 | 37811040 | 150 | -7.52 |
CAediting_1229414 | chr17_67471546_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811033 | 37811039 | 7mer-m8 | 37811019 | 37811040 | 150 | -7.52 |
CAediting_1229415 | chr17_67471547_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811033 | 37811039 | 7mer-m8 | 37811019 | 37811040 | 150 | -7.52 |
CAediting_1229413 | chr17_67471544_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811100 | 37811106 | 7mer-m8 | 37811085 | 37811107 | 147 | -8.84 |
CAediting_1229414 | chr17_67471546_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811100 | 37811106 | 7mer-m8 | 37811085 | 37811107 | 147 | -8.84 |
CAediting_1229415 | chr17_67471547_+ | ENSG00000165168.7 | ENST00000378588 | hsa-miR-548aa | 37811100 | 37811106 | 7mer-m8 | 37811085 | 37811107 | 147 | -8.84 |
CAediting_524911 | chr7_5495852_- | ENSG00000165168.7 | ENST00000378588 | hsa-miR-589-3p | 37812185 | 37812192 | 8mer-1a | 37812169 | 37812192 | 143 | -11.63 |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for CYBB |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for CYBB |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for CYBB |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for CYBB |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for CYBB |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
CYBB | P04839 | DB00514 | Dextromethorphan | Cytochrome b-245 heavy chain | SmallMoleculeDrug | approved |
Top |
RelatedDiseases for CYBB |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
CYBB | C1844376 | Granulomatous Disease, Chronic, X-Linked | 25 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
CYBB | C0020538 | Hypertensive disease | 4 | CTD_human |
CYBB | C0018203 | Chronic granulomatous disease | 2 | CTD_human;GENOMICS_ENGLAND |
CYBB | C1970859 | Atypical Mycobacteriosis, Familial, X-Linked 2 | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
CYBB | C3661525 | Autosomal Recessive Chronic Granulomatous Disease | 2 | CTD_human |
CYBB | C0002152 | Alloxan Diabetes | 1 | CTD_human |
CYBB | C0011849 | Diabetes Mellitus | 1 | CTD_human |
CYBB | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
CYBB | C0018801 | Heart failure | 1 | CTD_human |
CYBB | C0018802 | Congestive heart failure | 1 | CTD_human |
CYBB | C0022658 | Kidney Diseases | 1 | CTD_human |
CYBB | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
CYBB | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
CYBB | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
CYBB | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
CYBB | C0033687 | Proteinuria | 1 | CTD_human |
CYBB | C0035126 | Reperfusion Injury | 1 | CTD_human |
CYBB | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
CYBB | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
CYBB | C0393953 | Anterior Cerebral Circulation Infarction | 1 | CTD_human |
CYBB | C0751952 | Anterior Circulation Brain Infarction | 1 | CTD_human |
CYBB | C0751953 | Brain Infarction, Posterior Circulation | 1 | CTD_human |
CYBB | C0751954 | Venous Infarction, Brain | 1 | CTD_human |
CYBB | C0751955 | Brain Infarction | 1 | CTD_human |
CYBB | C1959583 | Myocardial Failure | 1 | CTD_human |
CYBB | C1961112 | Heart Decompensation | 1 | CTD_human |